A cost-effectiveness analysis of anemia screening before erythropoietin in patients with end-stage renal disease

This publication has 18 references indexed in Scilit:

• Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era
  American Journal of Kidney Diseases, 1995
• Transfusion requirements, risks, and costs for patients with malignancy
  Transfusion, 1995
• Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: A randomized, placebo-controlled trial
  The Journal of Pediatrics, 1995
• The Role of Iron and Other Factors in Patients Unresponsive to Erythropoietin Therapy
  Seminars in Dialysis, 1995
• Effectiveness of Subcutaneous Low-Dose Erythropoietin in Patients with Chronic Renal Failure despite Functional Iron Deficiency
  Nephron, 1995
• The Effect of Epoetin Beta (Recombinant Human Erythropoietin) on the Need for Transfusion in Very-Low-Birth-Weight Infants
  New England Journal of Medicine, 1994
• Effect of Serum Parathyroid Hormone and Bone Marrow Fibrosis on the Response to Erythropoietin in Uremia
  New England Journal of Medicine, 1993
• The Quality of Life of Hemodialysis Recipients Treated With Recombinant Human Erythropoietin
  JAMA, 1990
• Iron status in patients receiving erythropoietin for dialysis-associated anemia
  Kidney International, 1989
• Immunoreactive Parathyroid Hormone and in vitro Inhibition of Erythropoiesis by Uremic Serum in Patients on Continuous Ambulatory Peritoneal Dialysis
  American Journal of Nephrology, 1986